FindTrial
Sign In

Chinese medicine theory and follicular fluid metabolomics

Effects of Classical Prescription on Biomarkers Screening of The Aged IVF-ET Patients’ Follicle Fluid Based on The 'Neijing' 'Qi-Qi' Theory

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800014422
Enrollment
Unknown
Registered
2018-01-12
Start date
2018-01-31
Completion date
Unknown
Last updated
2018-01-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Old infertility

Interventions

Intervention group:Chinese herbal compound prescription
Control group:none

Sponsors

The Affiliated Hospital of Shandong University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 49 Years

Inclusion criteria

Inclusion criteria: Women of childbearing age of 18 to 49 years of normal chromosome.

Exclusion criteria

Exclusion criteria: Contraindication of in vitro fertilization embryo transfer.

Design outcomes

Primary

MeasureTime frame
Metabolome;—

Countries

China

Contacts

Public ContactSun Zhengao

The Affiliated Hospital of Shandong University of Traditional Chinese Medicine

sunzhengao77@126.com+86 13708938621

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 14, 2026